Company: MIRA
Filing Date: 2025-08-08
Form Type: DEFM14A
Source: 0001641172-25-022816
Chunk: 6

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-08-08
Form: DEFM14A
Chunk 6
---
 Time, or at any adjournment or postponement thereof. This proxy statement and the enclosed proxy card will be mailed to each stockholder entitled to notice of, and to vote at, the Annual Meeting of stockholders commencing on or about August 12, 2025.

You are cautioned not to rely on any information other than the information contained in or incorporated by reference into this proxy statement. No one has been authorized to provide you with information that is different from that contained in or incorporated by reference into this proxy statement. This proxy statement is dated August 8, 2025. You should not assume that the information contained in this proxy statement is accurate as of any other date, nor should you assume that the information incorporated by reference into this proxy statement is accurate as of any date other than the date of such incorporated document. The mailing of this proxy statement to our stockholders will not create any implication to the contrary.

This proxy statement does not constitute an offer to sell, or a solicitation of an offer to buy, any securities, or the solicitation of a proxy, in any jurisdiction in which or from any person to whom it is unlawful to make any such offer or solicitation in such jurisdiction.

<div align='center'>TABLE OF CONTENTS</div>

| QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING AND THE MERGER                                                                                                                                                                                                                                                  |     |  1 |
| SUMMARY                                                                                                                                                                                                                                                                                                         |     |  6 |
| MARKET PRICE AND DIVIDEND INFORMATION                                                                                                                                                                                                                                                                           |     | 11 |
| RISK FACTORS                                                                                                                                                                                                                                                                                                    |     | 12 |
| THE MERGER                                                                                                                                                                                                                                                                                                      |     | 24 |
| THE MERGER AGREEMENT                                                                                                                                                                                                                                                                                            |     | 34 |
| DESCRIPTION OF SKNY’S BUSINESS                                                                                                                                                                                                                                                                                  |     | 36 |
| MATTERS BEING SUBMITTED TO A VOTE OF MIRA’S STOCKHOLDERS                                                                                                                                                                                                                                                        |     | 50 |
| PROPOSAL NO. 1: APPROVAL OF THE ISSUANCE OF SHARES OF MIRA COMMON STOCK OR OTHER SECURITIES OF MIRA PURSUANT TO THE MERGER, WHICH WILL REPRESENT (OR ARE CONVERTIBLE INTO) MORE THAN 20% OF THE SHARES OF MIRA COMMON STOCK OUTSTANDING IMMEDIATELY PRIOR TO THE MERGER PURSUANT TO NASDAQ LISTING RULE 5635(A) |     | 50 |
| PROPOSAL NO. 2: APPROVAL OF POSSIBLE ADJOURNMENT